Patients’ Genetically Modified Cells Take Aim at Treating Lymphoma
16 mai 2019 08h00 HE | Franciscan Health
INDIANAPOLIS, Indiana, May 16, 2019 (GLOBE NEWSWIRE) -- Franciscan Health cancer doctors are using a new tool to treat patients whose lymphoma has returned after being in remission following...
Chimeric Antigen Receptor (CAR) T-cell Therapy Market to See 44.1% Annual Growth
14 août 2018 07h00 HE | BCC Research
WELLESLEY, Mass., Aug. 14, 2018 (GLOBE NEWSWIRE) -- Exciting developments in the world of immunotherapy are helping to drive incredible growth of the chimeric antigen receptor cell therapy market,...